A team of scientists led by Darío Acuña-Castroviejo, professor at the University of Granada (UGR), has published the results of a new breakthrough in molecular mechanisms of the anti-parkinsonian activity of melatonin.
The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study published in The American Journal of Psychiatry.
Researchers of the German Centre for Cardiovascular Research (DZHK) have discovered that patients with heart failure who have anorexia are also more affected in their physical functional capacity and have worse prognosis. Factors that encourage anorexia are the intake of diuretic medication, inflammation, and involuntary weight-loss.
UPM researchers, in collaboration with UCM and Hospital Universitario de la Princesa, have successfully simulated a system that alert patients to an incoming migraine crisis in real time. According to the simulation results, the reliability of this system is over 75 percent.
A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s University Belfast highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.
COPD patients suffer from chronic inflammation of the respiratory tract. Certain enzymes, so-called protein kinases, regulate the inflammation process. They are indirectly over-activated due to smoking, due to pro-inflammatory factors characteristic of COPD, and due to respiratory infections.
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
FocalSpec, the Finnish expert in high-precision quality control devices, will launch their first 3D imaging and metrology system UULA at MEDICA Trade Fair in Düsseldorf, Germany. UULA can be used both...
Ginolis, a global supplier of production automation and dispensing solutions, today announced a distributor agreement with Darwin Microfluidics, an online supplier of microfluidic kits, products and...
IMMS demonstrates prototype at MEDICA, Nov 13th – 16th, Hall 3/G60 13th November 2017. At the MEDCIA trade fair in Düsseldorf, Germany, IMMS presents via live-demo a passive RFID microelectronic chip...
Jena, November 13, 2017 - The success of FiLaC® therapy for the particularly painless and sphincter-friendly removal of anal fistulas from biolitec®, the technology leader in minimally invasive laser...
EFORE Plc, an international company which designs and manufactures custom and standard AC/DC power supplies and power systems, is pleased to announce it will showcase several new Medical Grade Power...
Global Good and Motic Introduce Breakthrough AI-Powered Microscope to Fight Drug-Resistant Malaria With machine learning technology, EasyScan GO automatically and accurately detects malaria parasites...
Image: A large stone is blocking a path that leads through a green meadow; Copyright: panthermedia.net/Brigitte Götz
These days, many groups make various demands of medical device developers: manufacturers, users, patients and government agencies. Given all of these interests and concerns, the developers face many challenges. In this interview, we put some of them under the microscope and examine how they can be sidestepped or entirely avoided.
Image: "Spray on" muscle fibers in a polymer scaffold; Copyright: Empa
Few patients with heart failure are fortunate enough to receive a donor's heart. Ventricular assist devices (or heart pumps) have been around for several years and are designed to buy time as patients wait for a transplant. Unfortunately, the body doesn't always tolerate these devices.
Image: View into a cockpit over the shoulders of the pilots; Copyright: panthermedia.net/natamc
What do intensive care medicine and aviation have in common? In both fields, mistakes can quickly put people's lives at risk. That's why high safety standards should be a matter of course for both. Having said that, medicine lags behind by comparison because staff members often lack the opportunities to train for emergency situations and the proper tools to prevent patients from being harmed.
A significant international impact has always been and remains MEDICA and COMPAMED’s trump card - visitors hail from over 130 countries
MEDICAlliance provides a one-stop shop for marketing power, enabling companies to access attractive markets and business in a range of countries
“MEDICA and COMPAMED have always had a high degree of international impact, and this remains their trump card. Top decision makers from around the world come together here and see the huge breadth of what we have on offer, which is the international frontrunner and has yet to be beaten”, Joachim Schäfer, Managing Director of Messe Düsseldorf, said, summing up the four-day run (from 13-16 November 2017) of the world’s biggest medical trade fair and the international leading specialist trade fair for the supplier market for the medical technology industry. Of a total of 123,500 professional visitors, over 60% came from countries outside Germany, from 130 different countries. Among these were visitor groups with members who were the top of their field, from China, India, Columbia and Nepal, along with visitor groups from the most important markets for medical technology in Europe who have attended for years and years.